|
7 Companies |
|
4 Products |
|
4 Products |
|
7 Mechanisms of Action |
|
1 Trial |
|
141 News |
|
| «123 |
- gentamicin sulfate / Generic mfg.
Trial completion: Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) (clinicaltrials.gov) - Nov 29, 2011
P2, N=30, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
Active, not recruiting --> Completed
- || pentoxifylline / Generic mfg.
New P2/3 trial, IO biomarker, Immunomodulating: Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis (clinicaltrials.gov) - Nov 1, 2011
P2/3, N=100, Recruiting, Sponsor: Centro Internacional de Entrenamiento e Investigaciones M
- gentamicin sulfate / Generic mfg.
Trial completion: Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama (clinicaltrials.gov) - Oct 25, 2011
P2, N=30, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | New P4 trial: Pharmacokinetics of Miltefosine in Children and Adults (clinicaltrials.gov) - Oct 24, 2011
P4, N=60, Recruiting, Sponsor: Centro Internacional de Entrenamiento e Investigaciones M
- Enrollment open: Bihar Evaluation of Social Franchising and Telemedicine (clinicaltrials.gov) - Oct 13, 2011
P=N/A, N=106380, Enrolling by invitation, Sponsor: Duke University
Active, not recruiting --> Completed Not yet recruiting --> Enrolling by invitation
- amphotericin b liposome / Generic mfg.
New P1/2 trial, Combination therapy: SCH708980 With and Without AmBisome for Visceral Leishmaniasis (clinicaltrials.gov) - Sep 18, 2011
P1/2, N=0, Withdrawn, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)